ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,792Medicare Part D Prescriptions Filled, Including Refills

Rank: 101 out of 5176

$1.26M Total Retail Price of All Prescriptions

Rank: 154 out of 5176

701 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 701 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 701 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 16,579 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
OMEPRAZOLE 882 727 1 3
LEVOTHYROXINE SODIUM 859 781 2 4
SIMVASTATIN 678 572 3 1
LISINOPRIL 667 564 4 5
METOPROLOL TARTRATE 648 578 5 6
FUROSEMIDE 620 560 6 8
AMLODIPINE BESYLATE 546 468 7 2
METFORMIN HCL 410 316 8 7
HYDROCODONE-ACETAMINOPHEN 396 327 S3 9 27
RANITIDINE HCL 315 263 10 36
WARFARIN SODIUM 279 228 11 13
MIRTAZAPINE 275 245 12 45
SERTRALINE HCL 274 236 13 30
DONEPEZIL HCL 272 259 14 28
METOPROLOL SUCCINATE 253 245 15 11
HYDROCHLOROTHIAZIDE 250 229 16 10
CITALOPRAM HBR 235 205 17 31
ATENOLOL 223 205 18 12
GABAPENTIN 219 191 19 21
SPIRIVA 217 170 20 54
NAMENDA 214 202 21 47
ATORVASTATIN CALCIUM 210 188 22 9
NITROGLYCERIN PATCH 194 164 23 149
DIGOXIN 187 185 24 56
ADVAIR DISKUS 186 132 25 32
ISOSORBIDE MONONITRATE ER 183 163 26 44
ROPINIROLE HCL 181 133 27 208
LOSARTAN POTASSIUM 176 174 28 14
AZITHROMYCIN 164 132 29 42
ALLOPURINOL 161 129 30 41
CLOPIDOGREL 157 142 31 26
METOCLOPRAMIDE HCL 155 127 32 176
TAMSULOSIN HCL 149 139 33 20
CYMBALTA 147 131 34 90
PREDNISONE 139 119 35 52
PLAVIX 138 128 36 29
LANTUS 135 115 37 66
ZOLPIDEM TARTRATE 132 99 38 17
TRAMADOL HCL 121 85 39 40
VENLAFAXINE HCL ER 118 47 40 186
DIVALPROEX SODIUM 117 96 41 104
TRAZODONE HCL 111 79 42 71
CARVEDILOL 110 103 43 24
POTASSIUM CHLORIDE 109 89 44 34
CRESTOR 106 88 45 15
LEVOFLOXACIN 105 97 46 109
GLIPIZIDE 104 91 47 63
RISPERIDONE 99 93 48 78
DILTIAZEM HCL 98 95 49 316
ESCITALOPRAM OXALATE 93 77 50 89
QUETIAPINE FUMARATE 92 81 51 75
PRIMIDONE 91 55 52 425
FAMOTIDINE 91 87 52 58
POLYETHYLENE GLYCOL 3350 88 78 54 74
SINGULAIR 88 69 54 62
INSULIN SYRINGE 80 72 56 137
FENTANYL 80 64 S2 56 172
HYDRALAZINE HCL 78 60 58 73
CEPHALEXIN 76 68 59 189
ALBUTEROL SULFATE 76 69 59 99
CARBIDOPA-LEVODOPA 74 53 61 98
GLIMEPIRIDE 73 68 62 37
LANTUS SOLOSTAR 71 55 63 70
NYSTATIN-TRIAMCINOLONE 69 69 64 142
PRAVASTATIN SODIUM 67 60 65 23
NEXIUM 66 51 66 16
DIOVAN 63 47 67 19
KLOR-CON M20 60 51 68 129
FLUOXETINE HCL 59 44 69 132
OXYBUTYNIN CHLORIDE 59 51 69 227
MONTELUKAST SODIUM 59 41 69 123
NOVOLOG 55 49 72 168
GLIPIZIDE XL 55 46 72 83
BUSPIRONE HCL 55 31 72 183
MELOXICAM 54 36 75 53
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 48 76 181
ALENDRONATE SODIUM 52 49 76 18
NYSTATIN 52 46 76 168
IPRATROPIUM-ALBUTEROL 52 52 76 138
JANUVIA 52 48 76 25
OXYBUTYNIN CHLORIDE ER 52 52 76 204
CLONIDINE HCL 51 32 82 79
CELEBREX 51 41 82 80
OLANZAPINE 51 38 82 140
VENTOLIN HFA 50 46 85 64
COMBIVENT 50 38 85 156
AMOXICILLIN 50 35 85 163
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.